BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21450967)

  • 41. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory.
    Zidarič V; Kotnik Kevorkijan B; Oresic N; Janezic S; Rupnik M
    J Med Microbiol; 2011 Aug; 60(Pt 8):1131-1136. PubMed ID: 21372187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effective modification of a commercial PCR assay for detection of methicillin-resistant or -susceptible Staphylococcus aureus in positive blood cultures.
    Munson E; Kramme T; Culver A; Hryciuk JE; Schell RF
    J Clin Microbiol; 2010 Apr; 48(4):1408-12. PubMed ID: 20147649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multi-laboratory comparison of two molecular methods for the detection of toxigenic Clostridium difficile.
    Halstead DC; Abid J; Sloan L; Meza D; Ramsey-Walker D; Hata DJ
    J Infect Dev Ctries; 2016 Jan; 10(1):62-7. PubMed ID: 26829538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection.
    Hicke B; Pasko C; Groves B; Ager E; Corpuz M; Frech G; Munns D; Smith W; Warcup A; Denys G; Ledeboer NA; Lindsey W; Owen C; Rea L; Jenison R
    J Clin Microbiol; 2012 Aug; 50(8):2681-7. PubMed ID: 22675134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM; Uslan DZ; Rubin Z
    J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
    Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
    LaSala PR; Ekhmimi T; Hill AK; Farooqi I; Perrotta PL
    J Clin Microbiol; 2013 Jan; 51(1):311-3. PubMed ID: 23135940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.
    Janezic S; Strumbelj I; Rupnik M
    J Clin Microbiol; 2011 Aug; 49(8):3024-5. PubMed ID: 21632902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
    Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the Liat Cdiff Assay for Direct Detection of Clostridioides difficile Toxin Genes within 20 Minutes.
    Hetem DJ; Bos-Sanders I; Nijhuis RHT; Tamminga S; Berlinger L; Kuijper EJ; Sickler JJ; Claas ECJ
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30944191
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection.
    Shin S; Kim M; Kim M; Lim H; Kim H; Lee K; Chong Y
    Ann Lab Med; 2012 Sep; 32(5):355-8. PubMed ID: 22950071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of polymerase chain reaction-based open reading frame typing method for the clonality investigation of Clostridioides difficile isolates.
    Ota Y; Hongou N; Nukui Y; Koike R; Tohda S; Saito R
    Anaerobe; 2021 Dec; 72():102462. PubMed ID: 34592472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.
    Cohen J; Limbago B; Dumyati G; Holzbauer S; Johnston H; Perlmutter R; Dunn J; Nadle J; Lyons C; Phipps E; Beldavs Z; Clark LA; Lessa FC;
    J Clin Microbiol; 2014 Feb; 52(2):632-4. PubMed ID: 24478500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.
    Camargo TS; Junior MS; Camargo LFA; Biotto VP; Doi AM; Koga PCM; França CN; Martino MDV
    Arch Microbiol; 2021 May; 203(4):1683-1690. PubMed ID: 33459815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
    Putsathit P; Morgan J; Bradford D; Engelhardt N; Riley TV
    Pathology; 2015 Feb; 47(2):165-8. PubMed ID: 25551308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.
    Rogers DS; Kundrapu S; Sunkesula VC; Donskey CJ
    J Clin Microbiol; 2013 Oct; 51(10):3421-2. PubMed ID: 23926162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific detection of toxigenic strains of Clostridium difficile in stool specimens.
    Gumerlock PH; Tang YJ; Weiss JB; Silva J
    J Clin Microbiol; 1993 Mar; 31(3):507-11. PubMed ID: 8458943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
    Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.